Why SPRAVATO®?
Reclaiming Hope:
A New Treatment Option
SPRAVATO® represents hope for individuals facing the challenges of Treatment-resistant Depression (TRD) and Major Depressive Disorder (MDD). Administered under strict medical supervision, this innovative therapy works differently from conventional antidepressants, targeting NMDA receptors in the brain to improve symptoms. While it’s not a replacement for hospitalization or a preventive measure against suicide, SPRAVATO® has helped many patients make significant progress in their mental health journey.
At PAX Institute, we are proud to offer SPRAVATO® (esketamine) nasal spray, a groundbreaking FDA-approved treatment for appropriate patients with:
Treatment-resistant depression (TRD) in adults.
Major depressive disorder (MDD) with suicidal thoughts or actions.
When combined with an oral antidepressant, SPRAVATO® provides a new path for those who have struggled to find relief with traditional therapies.
What to Expect from Your SPRAVATO® Treatment at PAX:
1. Before Your First Treatment
We’re here to ensure you feel supported every step of the way. Once SPRAVATO® is deemed right for you, our team will:
Guide you through the Patient Intake Form process.
Coordinate with your referring physician to ensure seamless care.
Work with your insurance provider to confirm coverage and costs.
2. On Treatment Days
Your comfort and safety are our priorities. Here’s what you can expect:
SPRAVATO® is self-administered in our relaxing treatment rooms, always under the direct supervision of a certified healthcare provider.
You will be monitored for at least two hours to observe for potential side effects such as blood pressure changes or sedation.
A caregiver or family member must drive you home after each session.
3. After Your Treatment
To ensure your safety:
Avoid driving or operating machinery until the next day after a full night of restful sleep.
Plan for your next appointment at our center, as SPRAVATO® cannot be self-administered at home.
Find relief with SPRAVATO®.
Safety First
At PAX Institute, we are certified under the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program to prescribe and administer this treatment. SPRAVATO® is only available through REMS-certified healthcare settings due to uncommon, but possible risks, including:
Sedation and dissociation.
Increased blood pressure.
Respiratory depression.
Potential for misuse or abuse.
Our medical team is trained to monitor and manage these effectively.
Do Not Take SPRAVATO® If You:
Have vascular disease (aneurysm), including in the brain, chest, abdominal aorta, arms, or legs.
Have an abnormal connection between veins and arteries (arteriovenous malformation).
Have a history of bleeding in the brain.
Are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®.
If you’re unsure about your medical history, discuss it with your healthcare provider before starting treatment.
Is SPRAVATO®
Right for You?
We understand the importance of finding a treatment that fits your unique needs. If you and your healthcare provider believe SPRAVATO® may be the next step in your care plan, reach out to us to learn more about the process and how we can support you on your journey to better mental health.
Take the first step toward healing.
Schedule a consultation with our expert team today.